Acute pancreatitis is a significant health concern, representing a leading cause for gastrointestinal-related hospitalizations. Its global incidence is on the rise, and the condition presents with varying degrees of severity, from mild cases requiring basic care to severe, complicated forms associated with high morbidity and mortality. Gallstones, alcohol consumption, and hypertriglyceridemia are among the most frequent culprits. The prevalence of each cause can differ based on geographical location and socioeconomic factors. This article provides a detailed overview of the diagnostic process for acute pancreatitis, tailored for expert automotive technicians at xentrydiagnosis.store, emphasizing the crucial role of accurate and timely diagnosis in patient management.
Understanding Pancreatitis: An Overview for Diagnosis
Acute pancreatitis, a prevalent condition and a primary cause of gastrointestinal hospital admissions in the US, involves acute pancreatic inflammation. Its severity spectrum ranges from mild, conservatively managed cases to severe, complex diseases with substantial morbidity and mortality. Mortality rates vary, from 3% in mild edematous pancreatitis to as high as 20% in cases involving pancreatic necrosis.[1] While recognizing acute presentation is generally straightforward, the real challenge lies in predicting disease progression and outcomes. The duration of the illness is a key factor in determining the necessary level of care.[2][3][4]
The Atlanta classification system categorizes acute pancreatitis into two main types:
- Interstitial edematous acute pancreatitis: Characterized by acute inflammation of the pancreatic tissue and surrounding tissues.
- Necrotizing acute pancreatitis: Defined by necrosis of the pancreatic tissue and surrounding peri-pancreatic tissue.[5]
Based on severity, acute pancreatitis is further classified as:
- Mild acute pancreatitis: Absence of local or systemic complications and organ failure.
- Moderately severe acute pancreatitis: Local complications with or without transient organ failure (less than 48 hours).
- Severe acute pancreatitis: Persistent organ failure (more than 48 hours) involving one or more organs.
The pancreas, a digestive gland located in the posterior abdominal wall in front of vertebrae L1 and L2, extends across the abdomen, positioned between the duodenum on the right and the spleen on the left. It consists of four parts: head, neck, body, and tail. The pancreatic head rests on the inferior vena cava and right renal vein, encircled by the duodenum. The tail reaches to the splenic hilum. The pancreas serves dual primary functions: exocrine and endocrine. Exocrine function involves secreting pancreatic juice (from acinar cells) into the duodenum via the main and accessory pancreatic ducts, while endocrine function involves releasing glucagon and insulin (from the islets of Langerhans) directly into the bloodstream.[6]
Etiology of Pancreatitis: Key Factors in Diagnosis
The most frequent causes of acute pancreatitis include gallstones, alcohol abuse, and hypertriglyceridemia (refer to Image. Acute Pancreatitis, Gallstones). The prevalence of each cause varies geographically and socioeconomically. Common etiologies are detailed below.[4][7][8]
- Gallstones: Obstruction of the bile duct can lead to pancreatic enzyme backflow.
- Alcohol Use: Chronic alcohol intake is a major risk factor for pancreatic inflammation.
- Hypertriglyceridemia: Elevated triglyceride levels can induce pancreatic injury.
- Drug-Induced Pancreatitis: Certain medications can trigger pancreatitis as a side effect.
- Idiopathic: In some cases, the cause remains undetermined despite thorough investigation.
- Post-Procedural: Procedures like ERCP or abdominal surgery can sometimes lead to pancreatitis.
- Ampullary Stenosis: Dysfunction of the sphincter of Oddi (formerly type I) can contribute.
- Autoimmune Pancreatitis: Both type I (IgG4-related) and type II autoimmune conditions are recognized.
- Viral Infections: Viruses such as Coxsackie, Cytomegalovirus, and HIV are implicated.
- Bacterial Infections: Bacteria like Campylobacter jejuni and Mycoplasma can be causative agents.
- Smoking: Smoking is identified as a significant risk factor.
- Trauma: Physical injury to the abdomen can induce pancreatitis.
- Congenital Anomalies: Conditions like annular pancreas are rare congenital causes.
- Genetic Disorders: Hereditary pancreatitis, cystic fibrosis, and alpha 1-antitrypsin deficiency are genetic predispositions.
- Hypercalcemia: High calcium levels can be a metabolic trigger.
- Parasitic Infections: Infections from parasites like Ascaris lumbricoides are less common causes.
- Renal Disease: Hemodialysis is associated with increased risk.
- Toxins: Scorpion bites and organophosphate poisoning are examples of toxic causes.
- Vasculitis: Conditions like polyarteritis nodosa can be underlying causes.
The causes of acute pancreatitis can be categorized as shown in the table below. See Image. Causes of Pancreatitis.
Table
Epidemiology of Pancreatitis: Understanding Incidence for Diagnosis
The incidence of acute pancreatitis is increasing globally, including in the United States. This rise may be due to increased detection and a true increase in cases, possibly linked to the rise in metabolic syndrome and hypertriglyceridemia. Hypertriglyceridemia is increasingly recognized as a secondary cause of acute pancreatitis. Despite the rising incidence, mortality rates in the US are decreasing, currently cited at approximately 2% in recent studies. Peak incidence occurs in the fifth and sixth decades of life, with mortality increasing with age. Geographic and socioeconomic variations in incidence are likely due to differences in alcohol consumption and biliary calculi prevalence, the two primary causes of acute pancreatitis. In the US, incidence is estimated at 600 to 700 per 100,000 people, with 200,000 to 250,000 annual hospital discharges for acute pancreatitis.[9][10]
Pathophysiology of Pancreatitis: Mechanisms for Diagnosis and Management
The pathophysiology of pancreatitis is characterized by localized pancreatic destruction and a systemic inflammatory response. The primary initiating event is the premature activation of trypsinogen to trypsin within pancreatic acinar cells instead of in the duct lumen. This premature activation is often due to increased ductal pressure (e.g., duct obstruction) and disruptions in calcium homeostasis and pH. Many pancreatitis-inducing toxins cause ATP depletion, leading to increased intra-acinar calcium concentrations, which can stimulate early trypsinogen activation, subsequently activating enzymes like elastase and phospholipases.
This premature enzyme activation results in significant tissue damage and the release of Damage Associated Molecular Patterns (DAMPs). DAMPs trigger neutrophil recruitment and initiate an inflammatory cascade, leading to systemic manifestations of acute pancreatitis. This cascade causes capillary permeability and endothelial damage, resulting in microvascular thrombosis and potentially multi-organ dysfunction syndrome (MODS), the leading cause of morbidity and mortality in acute pancreatitis.
Genetic predisposition also plays a role, with some individuals experiencing recurrent acute pancreatitis and progression to chronic pancreatitis. Genes involved in trypsinogen activation are implicated, including the cystic fibrosis transmembrane conductance regulator (CFTR) gene, gain-of-function mutations in the cationic trypsinogen gene (PRSS1), and mutations in the trypsin-degrading enzyme (CTCR) chymotrypsin C and (SPINK1) pancreatic secretory trypsin inhibitor. These genes are linked to the spectrum from acute to chronic pancreatitis.[3][11][12]
History and Physical Examination in Pancreatitis Diagnosis
Patients typically present with moderate to severe epigastric abdominal pain, often accompanied by nausea and anorexia. Pain characteristics can vary depending on the etiology. Biliary pancreatitis pain is often described as sharp, radiating to the back, with acute onset. Conversely, pain from metabolic or toxic causes like alcohol tends to be dull, generalized in the epigastrium, and with a more gradual onset. A detailed history should include alcohol use and medication review, noting that alcohol-related pancreatitis usually requires over 5 years of heavy use. Smoking history is also a significant risk factor.
Family history is crucial, particularly when common etiologies are less likely, as familial pancreatitis exists. Physical examination may reveal fever, tachycardia, and in severe cases, hypotension. Abdominal examination typically shows epigastric tenderness, possibly with guarding, rigidity, and reduced bowel sounds. In severe cases with retroperitoneal bleeding, Grey-Turner’s sign (flank ecchymosis) or Cullen’s sign (periumbilical ecchymosis from peritoneal hemorrhage) may be present.
Evaluation and Diagnosis of Pancreatitis: The Revised Atlanta Criteria
The Revised Atlanta Classification provides diagnostic criteria for acute pancreatitis, requiring at least 2 of the following 3 criteria:
- Elevated Pancreatic Enzymes: Lipase or amylase levels at least three times the upper limit of normal. This is a primary laboratory marker for pancreatitis diagnosis.
- Abdominal Pain Consistent with Pancreatitis: Epigastric pain that is acute onset, persistent, and may radiate to the back. Clinical presentation of pain is a key diagnostic factor.
- Imaging Findings Consistent with Pancreatitis: Abdominal imaging (CT, MRI, or ultrasound) showing pancreatic inflammation. Imaging confirms the diagnosis and assesses severity.
Initial evaluation to determine the etiology involves detailed history taking and laboratory assessments. Key historical points include symptoms or evidence of gallstone disease, unexplained weight loss or new-onset diabetes, alcohol abuse, medication use, prior surgery or trauma, hypertriglyceridemia or hypercalcemia history, autoimmune disease history, and family history of recurrent acute pancreatitis. See Image. Acute Pancreatitis, Signs and Symptoms.
Laboratory evaluation should include serum triglycerides, serum calcium, liver function tests, and genetic testing in cases with strong family history. Abdominal ultrasound is essential for assessing choledocholithiasis and bile duct dilation. Chest radiography may be obtained in moderate to severe cases to evaluate for pleural effusions, indicating increased severity. Computed tomography (CT) with intravenous contrast is recommended when diagnosis is uncertain or to rule out other conditions. CT is also crucial in cases failing to improve after 48 hours of resuscitation, to assess for necrosis (see Image. Peripancreatic Necrotic Fluid Shown on CT). The table below summarizes the diagnostic evaluation of suspected acute pancreatitis.
Table
When the etiology remains unclear after initial evaluation, gastroenterology consultation is often necessary for further investigation with magnetic resonance cholangiopancreatography (MRCP) or endoscopic ultrasound (EUS). MRCP, being non-invasive and not requiring contrast, is preferred but less sensitive for small biliary stones and chronic pancreatitis. EUS is often favored for its higher sensitivity. If MRCP and EUS are unavailable, pancreatic protocol CT is used. Diagnostic endoscopic retrograde cholangiopancreatography (ERCP) is not routine and is reserved for endotherapy in patients with MRCP/EUS abnormalities.[13][14][15]
Treatment and Management Strategies Following Pancreatitis Diagnosis
Early aggressive fluid resuscitation is the cornerstone of acute pancreatitis management. Lactated Ringer’s solution is typically used, starting with a 15 to 20 mL/kg bolus, followed by a 3 mL/kg/hour infusion (approximately 250 to 500 mL/hour) for the first 24 hours, unless contraindicated. Fluid resuscitation is monitored using labs (BUN, hematocrit) and urine output every 4 to 6 hours initially to adjust fluid rates. Lack of response to initial resuscitation suggests a higher risk of MODS and may necessitate escalation of care.[16][17][18] Recent studies suggest that overly aggressive fluid resuscitation may increase fluid overload without improving outcomes.[19][20]
Nutritional management is also critical. Traditionally, patients are kept NPO until symptoms improve. However, early feeding is now considered safe in mild pancreatitis and may not exacerbate symptoms. A soft, low-residue, low-fat diet is recommended initially, progressing to regular consistency as tolerated. In severe cases or when oral intake is insufficient, nasojejunal feeding is preferred over parenteral nutrition to maintain gut barrier function and minimize bacterial translocation. Prophylactic antibiotics are generally not recommended unless infection is suspected, in which case empiric antibiotics are started pending culture results, especially in cases of infected necrosis.
Pain management is a primary concern.[21] Most patients experience significant abdominal pain. While some guidelines may overlook pain management recommendations, others strongly advocate for pain assessment and pharmacological therapy, though details on analgesia type, dose, route, and frequency can be lacking.[22][23][24] The WHO analgesic ladder is often employed, starting with non-steroidal anti-inflammatory drugs and escalating to potent opioid analgesics, potentially with interventional strategies. Opioids like fentanyl and meperidine, and NSAIDs are commonly used. Contrary to past concerns about opioids causing sphincter of Oddi spasm, recent Cochrane reviews and meta-analyses show no increased risk of complications or adverse events with opioid use in acute pancreatitis pain management.[25][26][27]
Further management targets the underlying etiology. For gallstone pancreatitis, early cholecystectomy is strongly recommended. Early ERCP is beneficial in cases with concurrent cholangitis or clear biliary obstruction within 24 hours of presentation. In mild or resolving biliary pancreatitis, ERCP is reserved for distal biliary filling defects found during intraoperative cholangiography at cholecystectomy. For hypertriglyceridemia-induced pancreatitis, treatment aims to reduce triglyceride levels below 500 mg/dL, often using apheresis and insulin drips.
Local complications include early (less than 4 weeks: peripancreatic fluid collection, pancreatic/peripancreatic necrosis) and late (more than 4 weeks: pancreatic pseudocyst, walled-off necrosis) collections. Acute peripancreatic fluid collections usually resolve spontaneously; only a small percentage develop into pseudocysts. Observation with periodic imaging (CT or MRI) is often sufficient for pseudocysts unless infection or rapid enlargement occurs, in which case drainage (endoscopic, percutaneous) is indicated, with endoscopic drainage preferred.
Management of necrotic collections is complex. Sterile collections are intervened upon if symptomatic. Infected necrosis, occurring in about one-third of cases, leads to clinical deterioration, prolonged recovery, and high mortality. Antibiotics are started promptly upon suspicion of infection, typically carbapenems or quinolone/cefepime/ceftazidime with metronidazole. Gas bubbles on imaging suggest infected necrosis, confirmed by CT-guided aspiration culture. Surgical necrosectomy is considered for patients who worsen despite antibiotics. In stable patients, antibiotics may continue for 4-6 weeks, with necrosectomy after wall maturation. Initial approaches favor less invasive endoscopic or percutaneous drainage, reserving surgical debridement for unsuccessful cases.[28][29]
Differential Diagnosis in Pancreatitis
The differential diagnosis for acute pancreatitis broadly includes other causes of abdominal pain. A thorough history and physical exam, as detailed earlier, help narrow the possibilities. Differential diagnoses include:
- Peptic Ulcer Disease: Can present with epigastric pain, but often has different characteristics.
- Cholangitis: Biliary infection, may coexist with or mimic pancreatitis.
- Cholecystitis: Gallbladder inflammation, often distinguishable by ultrasound.
- Bowel Obstruction: Presents with abdominal distension and altered bowel sounds.
- Bowel Perforation: Surgical emergency with severe abdominal pain and peritonitis.
- Mesenteric Ischemia: Vascular emergency with severe pain, often out of proportion to exam findings.
- Acute Hepatitis: Liver inflammation, different lab profile.
- Diabetic Ketoacidosis: Metabolic emergency, hyperglycemia and acidosis are key features.
- Basilar Pneumonia: Can cause referred abdominal pain, respiratory symptoms are usually present.
- Myocardial Infarction: Especially inferior MI, can present with epigastric pain.
- Aortic Dissection: Vascular emergency with severe, tearing pain.
- Renal Colic: Flank pain radiating to groin, urinary symptoms.
Elevated lipase levels (3 times normal) are highly specific for pancreatitis, aiding in differentiation. Abdominal ultrasound helps distinguish cholecystitis. Suspicion of mesenteric ischemia warrants CT angiography. Cardiac causes should be ruled out in high-risk patients presenting with epigastric pain. Aortic dissection, though less common, should be considered due to its emergent nature, despite its typically more severe and tearing pain.
Pertinent Studies and Ongoing Trials in Pancreatitis Diagnosis and Management
A recent randomized controlled trial (RCT) published in the New England Journal of Medicine compared aggressive versus moderate fluid resuscitation in acute pancreatitis across 18 centers. Patients were randomized to aggressive fluid resuscitation (20 mL/kg bolus, 3 mL/kg/hour maintenance) or moderate resuscitation (10 mL/kg bolus only if hypovolemic, 1.5 mL/kg/hour maintenance). Fluid adjustments were made based on clinical status at 12, 24, 48, and 72 hours.
The primary outcome was development of moderately severe or severe acute pancreatitis. The primary safety outcome was fluid overload. Interim analysis of 249 patients led to trial termination due to safety concerns. Fluid overload incidence was significantly higher in the aggressive resuscitation group (20.5% vs 3%, adjusted relative risk 2.85, p=0.004). The study concluded that aggressive fluid resuscitation increased fluid overload without improving clinical outcomes.[19]
Prognosis in Pancreatitis: Severity Assessment for Diagnosis
Overall mortality for acute pancreatitis is approximately 1-2%, but severe acute pancreatitis has a considerably higher, albeit variable, mortality rate. Severity assessment is crucial for determining the level of care. Several clinical prediction scales exist, but many are complex and require 48-hour data. The International Association of Pancreatology and American Pancreatic Association guidelines suggest that persistent systemic inflammatory response syndrome (SIRS) beyond 48 hours predicts severe acute pancreatitis.[30] Persistent SIRS is associated with a 25% mortality rate compared to 8% for transient SIRS.[31] However, SIRS sensitivity and specificity for mortality prediction vary.
The Bedside Index for Severity in Acute Pancreatitis (BISAP) score is a simpler, validated tool, easily calculated from initial presentation data, with good predictive performance for severe acute pancreatitis and mortality. BISAP outperforms other scores like Ranson and APACHE II in specificity but has suboptimal sensitivity for mortality and severe acute pancreatitis.[34] A BISAP score of 0-2 indicates less than 2% mortality, while 3-5 indicates mortality greater than 15%.
Table
The modified CT Severity Index (CTSI), combining the Balthazar score and pancreatic necrosis assessment, can predict mortality. Necrosis on CT is a strong predictor of high mortality.[35] CTSI scores range from 0 to 10, with 0-2 indicating mild, 4-6 moderate, and 8-10 severe pancreatitis.
Table
Complications of Pancreatitis: Diagnostic and Management Implications
The table below summarizes acute pancreatitis complications.
Table
Consultations for Pancreatitis Management
Typical consultations for acute pancreatitis include:
- General Surgeon: For surgical interventions like cholecystectomy or necrosectomy.
- Radiologist: For diagnostic imaging interpretation and image-guided procedures.
- Gastroenterologist: For endoscopic procedures like ERCP and EUS, and overall management.
- Intensivist: For severe cases requiring ICU care and organ support.
- Pulmonologist: For respiratory complications like pleural effusions or ARDS.
- Endocrinologist: For managing metabolic complications, especially in hypertriglyceridemia-induced cases.
Deterrence and Patient Education for Pancreatitis
Patient education is crucial for preventing recurrent pancreatitis:
- Avoid self-driving to medical facilities during an attack.
- Seek help to stop alcohol consumption if alcohol-related pancreatitis is diagnosed.
- Adhere strictly to medication instructions.
- Follow a low-fat diet, with dietician support for meal planning.
- Learn to monitor pulse rate and understand when to seek medical help.
- Seek immediate medical attention for:
- Fever
- Severe abdominal pain
- Nausea and vomiting
- Dizziness or lightheadedness
- Jaundice (yellowing of skin or eyes)
- Rapid pulse
- Shallow, rapid breathing
- Abdominal swelling or tenderness
Pearls and Key Diagnostic Issues in Pancreatitis
- Acute pancreatitis pathophysiology involves premature enzyme activation, leading to pancreatic destruction and systemic inflammation (SIRS), potentially progressing to MODS.
- Revised Atlanta Criteria are used for diagnosis, requiring 2 of 3: elevated pancreatic enzymes, consistent clinical presentation, and consistent imaging findings.
- BISAP score helps triage patients and predict severity and mortality.
- Early fluid resuscitation in the first 12-24 hours is critical for reducing complications and mortality. Close monitoring of vitals and labs is essential.
- Idiopathic pancreatitis remains a diagnostic challenge in 10-20% of cases. EUS and MRCP are valuable, with a cautious approach to ERCP due to post-ERCP pancreatitis risk.
- Recent RCTs highlight the risks of overly aggressive fluid resuscitation without outcome improvement.
Enhancing Healthcare Team Outcomes in Pancreatitis Management
Effective management of acute pancreatitis requires an interprofessional team, including surgeons, radiologists, gastroenterologists, intensivists, pulmonologists, endocrinologists, pharmacists, nurses, and addiction specialists. Prevention is paramount. Nurses and pharmacists play a key role in patient education on risk reduction through alcohol abstinence, weight management, low-fat diets, and lipid profile management. Pharmacists can review medications and recommend discontinuing pancreatitis-associated drugs.[36][37][38] Open communication and meticulous record-keeping among team members are essential for optimal patient care and outcomes. This interprofessional approach yields the best patient results.
Outcomes in Pancreatitis
Acute pancreatitis remains a severe condition with a 5-15% mortality rate, influenced by etiology, patient age, and comorbidities. Gallstone pancreatitis often has higher mortality than alcoholic pancreatitis. Type 2 diabetes significantly increases complication and mortality risk. Multiorgan involvement can lead to mortality as high as 20%, primarily due to multiorgan failure and hypotensive shock. Various prognostic classifications exist, but many are complex for practical use.[39][40][41]
Review Questions
Figure
Figure
References
1.Werge M, Novovic S, Schmidt PN, Gluud LL. Infection increases mortality in necrotizing pancreatitis: A systematic review and meta-analysis. Pancreatology. 2016 Sep-Oct;16(5):698-707. [PubMed: 27449605]
2.Valverde-López F, Wilcox CM, Redondo-Cerezo E. Evaluation and management of acute pancreatitis in Spain. Gastroenterol Hepatol. 2018 Dec;41(10):618-628. [PubMed: 30149943]
3.Kahaleh M. Management of pancreatitis and pancreatic: fluid collections. Rev Gastroenterol Peru. 2018 Apr-Jun;38(2):169-182. [PubMed: 30118464]
4.Bazerbachi F, Haffar S, Hussain MT, Vargas EJ, Watt KD, Murad MH, Chari S, Abu Dayyeh BK. Systematic review of acute pancreatitis associated with interferon-α or pegylated interferon-α: Possible or definitive causation? Pancreatology. 2018 Oct;18(7):691-699. [PubMed: 30061072]
5.Ortiz Morales CM, Girela Baena EL, Olalla Muñoz JR, Parlorio de Andrés E, López Corbalán JA. Radiology of acute pancreatitis today: the Atlanta classification and the current role of imaging in its diagnosis and treatment. Radiologia (Engl Ed). 2019 Nov-Dec;61(6):453-466. [PubMed: 31153603]
6.Talathi SS, Zimmerman R, Young M. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Apr 5, 2023. Anatomy, Abdomen and Pelvis, Pancreas. [PubMed: 30422507]
7.Fonseca Sepúlveda EV, Guerrero-Lozano R. Acute pancreatitis and recurrent acute pancreatitis: an exploration of clinical and etiologic factors and outcomes. J Pediatr (Rio J). 2019 Nov-Dec;95(6):713-719. [PubMed: 30075118]
8.Barbara M, Tsen A, Rosenkranz L. Acute Pancreatitis in Chronic Dialysis Patients. Pancreas. 2018 Sep;47(8):946-951. [PubMed: 30113429]
9.de Pretis N, Amodio A, Frulloni L. Hypertriglyceridemic pancreatitis: Epidemiology, pathophysiology and clinical management. United European Gastroenterol J. 2018 Jun;6(5):649-655. [PMC free article: PMC6068776] [PubMed: 30083325]
10.Kirkegård J, Cronin-Fenton D, Heide-Jørgensen U, Mortensen FV. Acute Pancreatitis and Pancreatic Cancer Risk: A Nationwide Matched-Cohort Study in Denmark. Gastroenterology. 2018 May;154(6):1729-1736. [PubMed: 29432727]
11.Johnstone C. Pathophysiology and nursing management of acute pancreatitis. Nurs Stand. 2018 Jun 28; [PubMed: 29952150]
12.Constantinoiu S, Cochior D. Severe Acute Pancreatitis – Determinant Factors and Current Therapeutic Conduct. Chirurgia (Bucur). 2018 May-Jun;113(3):385-390. [PubMed: 29981669]
13.Choi HW, Park HJ, Choi SY, Do JH, Yoon NY, Ko A, Lee ES. Early Prediction of the Severity of Acute Pancreatitis Using Radiologic and Clinical Scoring Systems With Classification Tree Analysis. AJR Am J Roentgenol. 2018 Nov;211(5):1035-1043. [PubMed: 30160978]
14.Mandalia A, Wamsteker EJ, DiMagno MJ. Recent advances in understanding and managing acute pancreatitis. F1000Res. 2018;7 [PMC free article: PMC6039949] [PubMed: 30026919]
15.Smeets XJNM, Litjens G, Gijsbers K, Prokop M, Drenth JPH, Hermans J, van Geenen EJM. The Accuracy of Pancreatic Perfusion Computed Tomography and Angiography in Predicting Necrotizing Pancreatitis: A Systematic Review. Pancreas. 2018 Jul;47(6):667-674. [PubMed: 29894416]
16.Barrie J, Jamdar S, Smith N, McPherson SJ, Siriwardena AK, O’Reilly DA. Mis-use of antibiotics in acute pancreatitis: Insights from the United Kingdom’s National Confidential Enquiry into patient outcome and death (NCEPOD) survey of acute pancreatitis. Pancreatology. 2018 Oct;18(7):721-726. [PubMed: 30075909]
17.Reynolds PT, Brady EK, Chawla S. The utility of early cross-sectional imaging to evaluate suspected acute mild pancreatitis. Ann Gastroenterol. 2018 Sep-Oct;31(5):628-632. [PMC free article: PMC6102458] [PubMed: 30174401]
18.Sellers ZM, Abu-El-Haija M, Husain SZ, Morinville V. New Management Guidelines for Both Children and Adults With Acute Pancreatitis. Gastroenterology. 2018 Jul;155(1):234-235. [PubMed: 29890113]
19.de-Madaria E, Buxbaum JL, Maisonneuve P, García García de Paredes A, Zapater P, Guilabert L, Vaillo-Rocamora A, Rodríguez-Gandía MÁ, Donate-Ortega J, Lozada-Hernández EE, Collazo Moreno AJR, Lira-Aguilar A, Llovet LP, Mehta R, Tandel R, Navarro P, Sánchez-Pardo AM, Sánchez-Marin C, Cobreros M, Fernández-Cabrera I, Casals-Seoane F, Casas Deza D, Lauret-Braña E, Martí-Marqués E, Camacho-Montaño LM, Ubieto V, Ganuza M, Bolado F., ERICA Consortium. Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis. N Engl J Med. 2022 Sep 15;387(11):989-1000. [PubMed: 36103415]
20.Gardner TB. Fluid Resuscitation in Acute Pancreatitis – Going over the WATERFALL. N Engl J Med. 2022 Sep 15;387(11):1038-1039. [PubMed: 36103418]
21.Petrov MS, Yadav D. Global epidemiology and holistic prevention of pancreatitis. Nat Rev Gastroenterol Hepatol. 2019 Mar;16(3):175-184. [PMC free article: PMC6597260] [PubMed: 30482911]
22.Samarasekera E, Mahammed S, Carlisle S, Charnley R., Guideline Committee. Pancreatitis: summary of NICE guidance. BMJ. 2018 Sep 05;362:k3443. [PubMed: 30185473]
23.Crockett SD, Wani S, Gardner TB, Falck-Ytter Y, Barkun AN., American Gastroenterological Association Institute Clinical Guidelines Committee. American Gastroenterological Association Institute Guideline on Initial Management of Acute Pancreatitis. Gastroenterology. 2018 Mar;154(4):1096-1101. [PubMed: 29409760]
24.Leppäniemi A, Tolonen M, Tarasconi A, Segovia-Lohse H, Gamberini E, Kirkpatrick AW, Ball CG, Parry N, Sartelli M, Wolbrink D, van Goor H, Baiocchi G, Ansaloni L, Biffl W, Coccolini F, Di Saverio S, Kluger Y, Moore E, Catena F. 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg. 2019;14:27. [PMC free article: PMC6567462] [PubMed: 31210778]
25.Cai W, Liu F, Wen Y, Han C, Prasad M, Xia Q, Singh VK, Sutton R, Huang W. Pain Management in Acute Pancreatitis: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Front Med (Lausanne). 2021;8:782151. [PMC free article: PMC8718672] [PubMed: 34977084]
26.Basurto Ona X, Rigau Comas D, Urrútia G. Opioids for acute pancreatitis pain. Cochrane Database Syst Rev. 2013 Jul 26;(7):CD009179. [PubMed: 23888429]
27.Stigliano S, Sternby H, de Madaria E, Capurso G, Petrov MS. Early management of acute pancreatitis: A review of the best evidence. Dig Liver Dis. 2017 Jun;49(6):585-594. [PubMed: 28262458]
28.Arvanitakis M, Dumonceau JM, Albert J, Badaoui A, Bali MA, Barthet M, Besselink M, Deviere J, Oliveira Ferreira A, Gyökeres T, Hritz I, Hucl T, Milashka M, Papanikolaou IS, Poley JW, Seewald S, Vanbiervliet G, van Lienden K, van Santvoort H, Voermans R, Delhaye M, van Hooft J. Endoscopic management of acute necrotizing pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) evidence-based multidisciplinary guidelines. Endoscopy. 2018 May;50(5):524-546. [PubMed: 29631305]
29.Abu-El-Haija M, Kumar S, Quiros JA, Balakrishnan K, Barth B, Bitton S, Eisses JF, Foglio EJ, Fox V, Francis D, Freeman AJ, Gonska T, Grover AS, Husain SZ, Kumar R, Lapsia S, Lin T, Liu QY, Maqbool A, Sellers ZM, Szabo F, Uc A, Werlin SL, Morinville VD. Management of Acute Pancreatitis in the Pediatric Population: A Clinical Report From the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Pancreas Committee. J Pediatr Gastroenterol Nutr. 2018 Jan;66(1):159-176. [PMC free article: PMC5755713] [PubMed: 29280782]
30.Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology. 2013 Jul-Aug;13(4 Suppl 2):e1-15. [PubMed: 24054878]
31.Mofidi R, Duff MD, Wigmore SJ, Madhavan KK, Garden OJ, Parks RW. Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. Br J Surg. 2006 Jun;93(6):738-44. [PubMed: 16671062]
32.Buter A, Imrie CW, Carter CR, Evans S, McKay CJ. Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis. Br J Surg. 2002 Mar;89(3):298-302. [PubMed: 11872053]
33.Singh VK, Wu BU, Bollen TL, Repas K, Maurer R, Mortele KJ, Banks PA. Early systemic inflammatory response syndrome is associated with severe acute pancreatitis. Clin Gastroenterol Hepatol. 2009 Nov;7(11):1247-51. [PubMed: 19686869]
34.Gao W, Yang HX, Ma CE. The Value of BISAP Score for Predicting Mortality and Severity in Acute Pancreatitis: A Systematic Review and Meta-Analysis. PLoS One. 2015;10(6):e0130412. [PMC free article: PMC4474919] [PubMed: 26091293]
35.Mortele KJ, Wiesner W, Intriere L, Shankar S, Zou KH, Kalantari BN, Perez A, vanSonnenberg E, Ros PR, Banks PA, Silverman SG. A modified CT severity index for evaluating acute pancreatitis: improved correlation with patient outcome. AJR Am J Roentgenol. 2004 Nov;183(5):1261-5. [PubMed: 15505289]
36.Gódi S, Erőss B, Gyömbér Z, Szentesi A, Farkas N, Párniczky A, Sarlós P, Bajor J, Czimmer J, Mikó A, Márta K, Hágendorn R, Márton Z, Verzár Z, Czakó L, Szepes Z, Vincze Á, Hegyi P. Centralized care for acute pancreatitis significantly improves outcomes. J Gastrointestin Liver Dis. 2018 Jun;27(2):151-157. [PubMed: 29922760]
37.Branquinho D, Ramos-Andrade D, Elvas L, Amaro P, Ferreira M, Sofia C. Drug-Induced Acute Pancreatitis and Pseudoaneurysms: An Ominous Combination. GE Port J Gastroenterol. 2016 Nov-Dec;23(6):309-313. [PMC free article: PMC5580098] [PubMed: 28868485]
38.Srinivasan G, Venkatakrishnan L, Sambandam S, Singh G, Kaur M, Janarthan K, John BJ. Current concepts in the management of acute pancreatitis. J Family Med Prim Care. 2016 Oct-Dec;5(4):752-758. [PMC free article: PMC5353808] [PubMed: 28348985]
39.Jin T, Jiang K, Deng L, Guo J, Wu Y, Wang Z, Shi N, Zhang X, Lin Z, Asrani V, Jones P, Mittal A, Phillips A, Sutton R, Huang W, Yang X, Xia Q, Windsor JA. Response and outcome from fluid resuscitation in acute pancreatitis: a prospective cohort study. HPB (Oxford). 2018 Nov;20(11):1082-1091. [PubMed: 30170979]
40.Amas Gómez L, Zubia Olaskoaga F. Results of the modification of an acute pancreatitis management protocol in Intensive Care medicine. Med Intensiva (Engl Ed). 2019 Dec;43(9):546-555. [PubMed: 30072142]
41.Garret C, Péron M, Reignier J, Le Thuaut A, Lascarrou JB, Douane F, Lerhun M, Archambeaud I, Brulé N, Bretonnière C, Zambon O, Nicolet L, Regenet N, Guitton C, Coron E. Risk factors and outcomes of infected pancreatic necrosis: Retrospective cohort of 148 patients admitted to the ICU for acute pancreatitis. United European Gastroenterol J. 2018 Jul;6(6):910-918. [PMC free article: PMC6047289] [PubMed: 30023069]
